Cargando…
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071567/ https://www.ncbi.nlm.nih.gov/pubmed/32169110 http://dx.doi.org/10.1186/s13048-020-00628-5 |
_version_ | 1783506230954688512 |
---|---|
author | Wu, Huan Li, Rongrong Zhang, Zhiwei Jiang, Huiyang Ma, Hanlin Yuan, Cunzhong Sun, Chenggong Li, Yingwei Kong, Beihua |
author_facet | Wu, Huan Li, Rongrong Zhang, Zhiwei Jiang, Huiyang Ma, Hanlin Yuan, Cunzhong Sun, Chenggong Li, Yingwei Kong, Beihua |
author_sort | Wu, Huan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7071567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70715672020-03-18 Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer Wu, Huan Li, Rongrong Zhang, Zhiwei Jiang, Huiyang Ma, Hanlin Yuan, Cunzhong Sun, Chenggong Li, Yingwei Kong, Beihua J Ovarian Res Correction BioMed Central 2020-03-13 /pmc/articles/PMC7071567/ /pubmed/32169110 http://dx.doi.org/10.1186/s13048-020-00628-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Wu, Huan Li, Rongrong Zhang, Zhiwei Jiang, Huiyang Ma, Hanlin Yuan, Cunzhong Sun, Chenggong Li, Yingwei Kong, Beihua Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
title | Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
title_full | Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
title_fullStr | Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
title_full_unstemmed | Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
title_short | Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
title_sort | correction to: kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071567/ https://www.ncbi.nlm.nih.gov/pubmed/32169110 http://dx.doi.org/10.1186/s13048-020-00628-5 |
work_keys_str_mv | AT wuhuan correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT lirongrong correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT zhangzhiwei correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT jianghuiyang correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT mahanlin correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT yuancunzhong correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT sunchenggong correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT liyingwei correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer AT kongbeihua correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer |